A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
about
Topical treatments for scalp psoriasisOnce-daily topical treatment for psoriasis: calcipotriene + betamethasone two-compound topical formulationTopical therapies for the treatment of plaque psoriasis: systematic review and network meta-analysesUse of Topical Corticosteroids in Dermatology: An Evidence-based Approach.Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis: a consensus statement from the Asia Scalp Psoriasis Study Group.Update of the management of chronic psoriasis: new approaches and emerging treatment options.Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of ageCalcipotriene/betamethasone in the treatment of psoriasis: a review article.Hidradenitis suppurativa and pruritus ani.Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm MeetingMechanisms of action of topical corticosteroids in psoriasisA Preliminary, Open Label, Single-arm Study of Calcipotriene/Betamethasone Topical Suspension as a Supplement to Non-biologic Systemic Therapy for Psoriasis.A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis.Scalp psoriasis: European consensus on grading and treatment algorithm.Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.Topical psoriasis therapy in the age of biologics: evidence-based treatment recommendations.Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities.Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review.Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic literature review.Topical treatments for chronic plaque psoriasis of the scalp: a systematic review.Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.Current challenges and emerging drug delivery strategies for the treatment of psoriasis.Topical treatments for scalp psoriasis: summary of a Cochrane Systematic Review.Managing Scalp Psoriasis: An Evidence-Based Review.Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.Vitamin D, steroid hormones, and autoimmunity.Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice.Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patients.Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.Long-term management of scalp psoriasis: perspectives from the International Psoriasis Council.Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European analysis.Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis.Prolonged skin retention of clobetasol propionate by bio-based microemulsions: a potential tool for scalp psoriasis treatment.Treatment adherence: a hurdle for real-life effectiveness in psoriasis?[Psoriasis in special localizations].Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability.
P2860
Q24186104-ABA1BF08-5BB5-45D8-85A7-8E046DC02922Q27002902-A95E713A-7D53-48A6-8409-B832388A7061Q27003961-7AE24BAE-459E-4A60-A5F7-7CD92321C2CCQ33737957-2EF8359F-710E-42B4-9F1F-4FBAEC9FEFFDQ34221011-5131BF75-23A9-4850-86B3-DF8546B2EA31Q34412891-302D3C91-FD31-450A-9AB8-4ECB5087A45AQ34452903-07D749EF-0BB6-4CE5-890D-DEA39F1A6E94Q34620375-17960B10-48C1-4C52-9808-986FD78383FBQ34982047-7A79F415-AD68-440C-A878-ADF8159EC8B5Q34996165-05056AEE-C1AF-44A3-AE59-12162C7AD287Q35117973-A8F4E9A9-1D5C-4F11-A6AE-45E225EBE832Q35817223-465163B4-C7BC-4F5B-9182-189FC2B03E26Q35822379-0D02D83D-F618-4CF8-9CA4-C04231174BC7Q36429698-F0B1C2BC-F1CB-4BE3-B069-149954480E3FQ36982667-EA90FA95-7D94-4ABC-90B9-5E48107B4684Q37466717-2D909252-1D7D-46F0-B507-E76E1B1B900CQ37554785-FD95FC46-3B3E-4850-8C57-529150C59CC2Q37866759-74114343-2FDD-48B3-A942-375BAD098F0AQ37874681-F6AF1375-AAA2-4902-9561-632BF23EDE49Q37971835-67ACF4A3-A315-4C5A-BAFA-7859D1081AB3Q38003484-3F080E4A-2B8E-4659-A2C5-3BE1F058D9BDQ38003486-B4C68B7A-0A9E-4F85-B708-5BCC382EDD6CQ38070821-E8811568-5217-4A26-A4F7-D86A4F1A9F20Q38116596-280E6167-4E6D-4585-B42F-B88AF5D06BD8Q38811080-B32291B2-5647-4E7F-BBE5-6A014EF68301Q38831055-5C791AE5-D0C5-47A6-A60D-6F9A90AB1054Q38867776-12F9E551-02FD-4409-88F5-2822C9391CECQ38960080-DEBE0D19-6303-48DC-A559-1586CC2757F8Q40816333-840669AF-FD2F-4E09-8591-0EF113705EE7Q42219099-2998BA1E-AEAE-43C6-9B7B-A044704824B7Q43646014-0A13625D-6898-45F0-9F58-EC1C4C03F8A4Q43714903-8BCC7998-5E56-4FDF-B016-4148FA5D1107Q44288342-BBA88AE7-87CB-4A33-9576-266F7664F175Q44698309-7AD0A118-15C6-4A4D-AD13-382AD1A3964AQ45758119-1630EED9-E28F-4AB6-883E-660B0272C31AQ45928983-239FF989-02B3-47AA-8A7B-44C55099D7C1Q47664406-71553465-93BA-48FA-A057-B6C578341DD4Q48081427-B1221AFE-D467-4CB1-BFBF-FE2D093B8FAEQ52851991-07160753-86CC-4941-B1D6-43316598D819Q54973760-6A2EFB48-99CB-44DE-80AE-CB983099C1F1
P2860
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
A new scalp formulation of cal ...... ouble-blind, controlled trial.
@en
A new scalp formulation of cal ...... ouble-blind, controlled trial.
@nl
type
label
A new scalp formulation of cal ...... ouble-blind, controlled trial.
@en
A new scalp formulation of cal ...... ouble-blind, controlled trial.
@nl
prefLabel
A new scalp formulation of cal ...... ouble-blind, controlled trial.
@en
A new scalp formulation of cal ...... ouble-blind, controlled trial.
@nl
P2093
P1476
A new scalp formulation of cal ...... ouble-blind, controlled trial.
@en
P2093
A David Burden
Berit Berne
Cecilia Ganslandt
Jean-Paul Ortonne
Joar Austad
Pablo de Unamuno
Yves Poulin
P304
P356
10.1016/J.JAAD.2008.04.027
P407
P577
2008-09-01T00:00:00Z